JAMES MICHEFF: Open Payments
NPI 1841703477 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 29 payments from 14 companies in 2025. Trend: 2023 $1,623 · 2024 $1,383 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $188 |
| ABBVIE INC. | 3 | $151 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $42 |
| GENZYME CORPORATION | 1 | $42 |
| Lilly USA, LLC | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| Kerecis Limited | 2 | $27 |
| Organogenesis Inc. | 1 | $24 |
Products named: LIBTAYO, RINVOQ, DUPIXENT, COSENTYX, TREMFYA, NEMLUVIO, ILUMYA, Kerecis SurgiClose.
Industry payments across GA — which companies pay providers there.
